Deep Track Capital, LP Relmada Therapeutics, Inc. Call Options Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
Call Options
1 transactions
Others Institutions Holding RLMD
# of Institutions
101Shares Held
14.3MCall Options Held
82KPut Options Held
73.9K-
Vanguard Group Inc Valley Forge, PA1.26MShares$3.76 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY1.2MShares$3.59 Million0.46% of portfolio
-
Acadian Asset Management LLC Boston, MA1.18MShares$3.53 Million0.02% of portfolio
-
Parsons Capital Management Inc974KShares$2.91 Million0.31% of portfolio
-
Opaleye Management Inc. Boston, MA759KShares$2.27 Million0.86% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $85.5M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...